Pasteurized blood samples for transfusion compatibility testing during the coronavirus disease 2019 outbreak

Run Yao, Yamei Shen, Ying Tan, Pengcheng Zhou, Bijuan Li, Xuegong Fan, Ning LiInfection 2020 · DOI

Introduction

During the early stages of the COVID-19 pandemic, clinical laboratories faced significant safety challenges. While SARS-CoV-2 is primarily a respiratory pathogen, its presence in blood posed a risk to technicians, particularly during procedures like centrifugation that generate infectious aerosols. In resource-limited settings where advanced biosafety equipment may be unavailable, finding a simple method to neutralize the virus before testing was critical. This study investigates whether pasteurizing blood samples at 56°C for 30 minutes—a protocol known to inactivate SARS-CoV-2—interferes with essential transfusion compatibility tests.

Methodology

Researchers at Xiangya Hospital, Central South University, employed a split-sample experimental design. Clinical blood samples (covering types A, B, O, and AB with various Rh factors) were divided into two groups: an untreated control group and an experimental group pasteurized at 56°C for 30 minutes. The team then performed a battery of standard tests, including ABO and Rh typing, irregular antibody screening, and cross-matching, to determine if heat treatment compromised diagnostic accuracy.

Results: Antigen Stability and Rh Typing

The study found that ABO antigens on red blood cells are remarkably resilient to heat. Agglutination intensity for ABO typing remained at a maximum "4+" score in both heated and unheated samples. However, the Rh D-antigen showed a slight decrease in reactivity following pasteurization.

Figure 4: Comparison of ABO and Rh typing results between pre-treatment and post-treatment samples using the classic test-tube method.

As shown in Figure 4, while the ABO results remained consistent, the Rh D-antigen (column D) often saw a reduction in agglutination intensity from 4+ to 2+ or 3+. Crucially, these results remained clearly positive, ensuring that no false negatives occurred despite the slight "heat tax" on reactivity.

Results: Antibody Screening and Cross-matching

Similar to the Rh D-antigen, certain irregular antibodies exhibited reduced reactivity after heat treatment. High-intensity (4+) reactions were often reduced to 3+ intensity, while negative and low-intensity samples remained stable.

Figure 3: Antibody screening results across various reaction intensities (-, ±, 1+, 2+, 3+, 4+) comparing pre-treatment and post-treatment samples.

Figure 3 illustrates that while the intensity of the reaction bands in the gel microcolumn cards may shift slightly for higher-grade antibodies, the diagnostic outcome remains interpretable. Primary cross-matching showed no observable negative effects from the pasteurization process.

Discussion: Technical Considerations and Clinical Outcomes

A key technical insight from the study involves the "fragmentation trap." Heat treatment causes some red blood cells to rupture (hemolysis), creating fragments that can become trapped in gel microcolumn cards, potentially leading to false positives. Consequently, the authors recommend using the classic test-tube method for typing heat-treated blood, while the anti-human-globulin card method remains suitable for antibody screening.

Clinical validation was performed on patients with suspected COVID-19 who required red blood cell transfusions. Transfusions based on these heat-treated compatibility tests were successful; patients showed improved clinical symptoms and expected rises in 24-hour hemoglobin levels without any adverse hemolytic reactions.

Conclusion

Pasteurizing blood samples at 56°C for 30 minutes is a viable, low-cost safety measure for laboratories in high-risk or low-resource environments. While it slightly reduces the intensity of Rh and antibody reactions, it does not compromise the fundamental accuracy of transfusion compatibility testing, providing a pragmatic solution to protect laboratory personnel from viral exposure.

Summary updated

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the 'Save PDF' action button.
BibTeX
@inproceedings{yao2020pasteurized,
  author = {Run Yao and Yamei Shen and Ying Tan and Pengcheng Zhou and Bijuan Li and Xuegong Fan and Ning Li},
  title = {{Pasteurized blood samples for transfusion compatibility testing during the coronavirus disease 2019 outbreak}},
  booktitle = {Infection},
  year = {2020},
  doi = {10.1017/ice.2020.138},
}
Figure